Two Sigma Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $86.8M | Sell |
266,100
-9,700
| -4% | -$3.16M | 0.18% | 125 |
|
2025
Q1 | $74.5M | Buy |
275,800
+197,000
| +250% | +$53.2M | 0.17% | 126 |
|
2024
Q4 | $18.5M | Sell |
78,800
-24,300
| -24% | -$5.72M | 0.04% | 337 |
|
2024
Q3 | $28.4M | Sell |
103,100
-155,600
| -60% | -$42.8M | 0.07% | 252 |
|
2024
Q2 | $62.9M | Buy |
258,700
+69,100
| +36% | +$16.8M | 0.14% | 140 |
|
2024
Q1 | $28.3M | Buy |
+189,600
| New | +$28.3M | 0.07% | 271 |
|
2023
Q4 | – | Sell |
-35,900
| Closed | -$6.36M | – | 2486 |
|
2023
Q3 | $6.36M | Sell |
35,900
-157,700
| -81% | -$27.9M | 0.02% | 631 |
|
2023
Q2 | $36.8M | Buy |
193,600
+38,500
| +25% | +$7.31M | 0.09% | 214 |
|
2023
Q1 | $31.1M | Buy |
155,100
+35,100
| +29% | +$7.03M | 0.08% | 235 |
|
2022
Q4 | $28.5M | Buy |
120,000
+56,200
| +88% | +$13.4M | 0.08% | 247 |
|
2022
Q3 | $12.8M | Buy |
63,800
+51,400
| +415% | +$10.3M | 0.04% | 436 |
|
2022
Q2 | $1.81M | Sell |
12,400
-34,300
| -73% | -$5M | 0.01% | 1269 |
|
2022
Q1 | $7.63M | Buy |
46,700
+42,900
| +1,129% | +$7.01M | 0.02% | 624 |
|
2021
Q4 | $644K | Buy |
+3,800
| New | +$644K | ﹤0.01% | 1781 |
|
2021
Q2 | – | Sell |
-31,900
| Closed | -$4.5M | – | 2434 |
|
2021
Q1 | $4.5M | Buy |
31,900
+28,200
| +762% | +$3.98M | 0.01% | 891 |
|
2020
Q4 | $481K | Buy |
+3,700
| New | +$481K | ﹤0.01% | 1878 |
|
2020
Q3 | – | Sell |
-8,300
| Closed | -$1.23M | – | 2384 |
|
2020
Q2 | $1.23M | Buy |
+8,300
| New | +$1.23M | ﹤0.01% | 1474 |
|
2019
Q2 | – | Sell |
-70,800
| Closed | -$6.62M | – | 2298 |
|
2019
Q1 | $6.62M | Sell |
70,800
-46,300
| -40% | -$4.33M | 0.02% | 748 |
|
2018
Q4 | $8.54M | Sell |
117,100
-72,400
| -38% | -$5.28M | 0.02% | 613 |
|
2018
Q3 | $16.6M | Sell |
189,500
-44,322
| -19% | -$3.88M | 0.04% | 442 |
|
2018
Q2 | $23M | Sell |
233,822
-123,400
| -35% | -$12.2M | 0.06% | 360 |
|
2018
Q1 | $42.5M | Buy |
357,222
+248,200
| +228% | +$29.6M | 0.12% | 228 |
|
2017
Q4 | $13.9M | Buy |
+109,022
| New | +$13.9M | 0.04% | 498 |
|
2016
Q2 | – | Sell |
-101,622
| Closed | -$6.38M | – | 2039 |
|
2016
Q1 | $6.38M | Buy |
101,622
+97,300
| +2,251% | +$6.11M | 0.04% | 447 |
|
2015
Q4 | $407K | Buy |
+4,322
| New | +$407K | ﹤0.01% | 1404 |
|
2015
Q3 | – | Sell |
-5,022
| Closed | -$602K | – | 1794 |
|
2015
Q2 | $602K | Sell |
5,022
-1,500
| -23% | -$180K | ﹤0.01% | 1354 |
|
2015
Q1 | $681K | Sell |
6,522
-900
| -12% | -$94K | 0.01% | 1220 |
|
2014
Q4 | $720K | Buy |
+7,422
| New | +$720K | 0.01% | 1220 |
|